You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Relvar Ellipta contains two medicines, fluticasone furoate and vilanterol. Relvar Ellipta is a long-acting bronchodilator combined with an inhaled corticosteroid that is taken once daily for the treatment of asthma and COPD.*

Safety information

This link will take you to www.medicines.ie which is a non-GSK website.

Relvar Ellipta PIL

Patient information

This guide can help you make the most of your treatment, but if you have any questions or concerns just ask your doctor, nurse or pharmacist and read the patient information leaflet provided with your medicine.

I am a patient

Further information

Find links to professional organisations, charities and other useful websites for asthma and COPD.

Further information

* Relvar Ellipta is indicated for the regular treatment of asthma and COPD. (Asthma - in adults and adolescents aged 12 years and older; COPD - in adults; please refer to PIL and SPC links above for further information)

If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Website: www.hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine.

Relvar and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies